Job Description

　　Our company in the United States and Canada, is a global health care leader with a diversified portfolio of prescription medicines, vaccines, and animal health products. Our Research Scientists are our Inventors. We identify and target steps in disease mechanisms or pathways that could be inhibited or enhanced. Our goal is to identify and isolate a molecule that is effective against a disease target. Using innovative thinking, state-of-the-art facilities and robust scientific methodology we collaborate to discover and develop the next medical breakthrough. Our company's success is backed by ethical integrity, forward momentum, and an inspiring mission to achieve new milestones in global healthcare.

　　Sterile & Specialty Products team is responsible for the research and development of sterile & parenteral drug products for a range of modalities including small molecules, biologics, peptides, oligonucleotides and other intermediate modalities. Within Sterile & Specialty Products, the large molecule product development Director will influence the strategy, lead activities, and develop a team whose roles include design and development of formulation, manufacturing process, and primary packaging to enable phase appropriate regulatory filings for large molecule sterile products. These sterile products include those administered via intravenous, subcutaneous, or intramuscular routes of administration. This research opportunity is fast paced and contributes to the Pharmaceutical Sciences and Clinical Supplies deliverable which is the development of robust compositions, processes and device/ packaging that enable patient centric products for patients. The successful candidate:

　　Should have a vision to develop a team, demonstrated leadership skills, sterile product technical & domain expertise, effective communication skills, understanding of regulatory environment, and vision to influence the regulatory environment

　　Will lead sub-functional strategic planning, coordinating, and execution of Sterile & Specialty Products initiatives for the company's portfolio from discovery to launch.

　　Will need to Collaborate in a fast-paced, integrated, multidisciplinary team environment with key stakeholders across the organizations within our Research & Development Divisionand Manufacturing Division, such as Quality, Regulatory CMC, and technical functions, to ensure timebound progression of portfolio, initiatives for scientific & operational excellence, and other strategic goals that advance functional impact.

　　The incumbent will drive large molecule sterile portfolio while developing new ways of working to meet aggressive timeline requirements and integrate within the broader parenteral portfolio, where appropriate. The incumbent will also have to demonstrate domain expertise in sterile product development and collaborate effectively with multiple stakeholders across both our Research & Development Division and our Manufacturing Division - in particular Discovery Pharmaceutical Sciences, Biologics Analytical Research and Development, Bioprocess research and development, and Sterile Product Development & Commercialization in the design of new formulations and development of robust and scalable processes for commercial products. The applicant will preferably have experience with hybrid modalities like antibody drug conjugates (ADCs) and fusion proteins to support clinical and commercial development. Maintaining a strong network internally and across the external academic and regulatory community is expected, as well as advancing a culture of scientific excellence, GMP and compliance mindset and collaboration with various partners and stakeholders in development.

　　The Director will report to the Executive Director of Sterile & Specialty Product Development, have 8-10 direct reports composed of experienced, senior and associate scientists. The successful candidate will be effectively team with Sterile & Specialty Products leadership and extended leadership teams to implement strategy, conduct scientific research from the laboratory to commercial scale, step across boundaries and implement novel innovations during drug product development to enable best science at first filing for parenteral development processes for human health while ensuing a phase appropriate approach during early development.

　　The incumbent will be responsible for the recruiting, appraisal, and development of personnel under her/his supervision to their full potential. The Director selects, trains, and effectively recommends transfers, merit increases, promotions, and closures of personnel under her/his direction within the framework of Company policy. The role will also be responsible for proactive resourcing planning, risk assessment strategies and budget management as necessary. The candidate will also have a proven track record of developing talent from a diverse scientific background and will have the ability to advance ouor company's commitment to a diverse and inclusive work environment.

　　Essential Knowledge, Duties & Responsibilities for the Director Include:

　　Sterile drug product development concepts, tools, and requirements for all dosage forms (liquid, lyo, drug-device combinations)

　　Review and approval of data and technical documents

　　Ability to recruit, select, develop, and mentor talent.

　　Strategic and critical thinking to advance Sterile & Specialty Products strategy

　　Project management skills

　　Builds collaborations across internal company departments and key stakeholders.

　　Ability to lead and champion organizational structure and be a change agent when necessary.

　　Developing the departmental budget and meeting the agreed upon spend.

　　Collaborates and builds strong relationships with upper management and other disciplines to select and qualify new CMOs/CROs/CDMOs

　　Qualifications:

　　Education:

　　Ph.D. in pharmaceutical sciences, pharmaceutics, biochemical / biomedical engineering, chemical engineering, biology, virology, or relevant field with minimum of 8 years of industrial experience.

　　B.S. or M.S. in biochemistry, biology, chemistry, pharmaceutical sciences, biochemical / biomedical engineering, chemical engineering, or relevant field with minimum of 10 years of industrial experience

　　Required:

　　Relevant experience in pharmaceutical development with exposure to all stages and aspects of development (pre-clinical, clinical, and commercial) and cGMP industrial background.

　　Experience with design of IV and SC drug products including drug-device combination products for biologics and hybrid modalities (ADCs, fusion proteins)

　　Experience with process design and/or scale-up in the clinical or commercial space, including process flow diagrams & engineering drawings

　　Process development and technology transfer experience Including the use of risk assessment and process capability (Ppk) tools.

　　Candidate should have solid understanding of integration and partnering for Pharmaceutical development/ CMC with Quality, Regulatory, Operations, Non-clinical, Clinical, and other functional areas

　　Experience with regulatory submissions including writing / review of regulatory filings including INDs and NDAs.

　　Exposure to project / engineering work process and deliverables (e.g. equipment fabrication, FAT, SAT, Validation etc.)

　　Must be innovative and drive new ideas, but also have pragmatic approach to development options, technology selection and regulatory posture

　　Demonstrated working knowledge of FDA, ICH, and other regulatory requirements for CMC. Strong experience in safety and environmental knowledge and site presence.

　　Excellent verbal and written communication skills, demonstrated creativity, strong interpersonal and collaboration skills.

　　A strong track record of publications in parenteral drug product development and/or delivery

　　Demonstrated ability to lead cross-functional teams with proven talent development skillsets.

　　Demonstrated strength in delivering results on firm deadlines in support of product discovery, process development and commercial filings for biopharmaceuticals or vaccine products.

　　Preferred Experience and Skills:

　　Experience in developing broad suite of sterile & specialty products (e.g. include long acting injectable suspensions, implants, inhalation products, sterile liquid/ lyophilized products, and particle based delivery systems). Knowledge of intermediate modality evaluations, delivery technology development and understanding of parenteral formulation development.

　　Expertise in novel delivery technologies (e.g. LNP, LAI) for small molecule or synthetic modalities for clinical and/or commercial manufacturing would be ideal

　　Knowledgeable of the Capital Process having participated on a large capital project team

　　Experience in regulatory compliance expectations across all phases of product development to commercialization.

　　Demonstrated leadership skills and organization design (i.e. building high performing teams, building talent, and shown to be able to motivate, influence scientific team; lead by example through past scientific / technical expertise).

　　Experience in budget planning & management, establishing development strategies, and managing scientific staff from a budgetary and personnel decisions standpoint.

　　Experience in equipment Fabrication, FAT/SAT, start-up, qualification and/or validation is preferred

　　Fill/finish process scale-up, Drug Delivery and/or technology transfer experience including the use of gap analysis and risk assessment tools

　　Highly motivated, flexible, a change agent, and ability to work in a fast-paced environment.

　　Willing to implement novel and innovative technologies into sterile & specialty programs. Encourages innovative thinking / risk-taking and eliminates obstacles / barriers to implement change

　　Ability to present clear and compelling quality and business cases. Ability to engage and align other stakeholders outside the project team.

　　Ability to apply and promote a growth mindset with teams and partnerships

　　NOTICE FOR INTERNAL APPLICANTS

　　In accordance with Managers' Policy - Job Posting and Employee Placement, all employees subject to this policy are required to have a minimum of twelve (12) months of service in current position prior to applying for open positions.

　　If you have been offered a separation benefits package, but have not yet reached your separation date and are offered a position within the salary and geographical parameters as set forth in the Summary Plan Description (SPD) of your separationpackage, then you are no longer eligible for your separation benefits package. To discuss in more detail, please contact your HRBP or Talent Acquisition Advisor.

　　Employees working in roles that the Company determines require routine collaboration with external stakeholders, such as customer-facing commercial, or research-based roles, will be expected to comply not only with Company policy but also with policies established by such external stakeholders (for example, a requirement to be vaccinated against COVID-19 in order to access a facility or meet with stakeholders). Please understand that, as permitted by applicable law, if you have not been vaccinated against COVID-19 and an essential function of your job is to call on external stakeholders who require vaccination to enter their premises or engage in face-to-face meetings, then your employment may pose an undue burden to business operations, in which case you may not be offered employment, or your employment could be terminated. Please also note that, where permitted by applicable law, the Company reserves the right to require COVID-19 vaccinations for positions, such as in Global Employee Health, where the Company determines in its discretion that the nature of the role presents an increased risk of disease transmission.

　　Current Employees apply HERE (https://wd5.myworkday.com/msd/d/inst/1422$1533/rel-task/3001$14.htmld)

　　Current Contingent Workers apply HERE (https://wd5.myworkday.com/msd/d/task/1422$4020.htmld)

　　US and Puerto Rico Residents Only:

　　Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please click here (https://survey.sogosurvey.com/r/aCdfqL) if you need an accommodation during the application or hiring process.

　　We are an Equal Opportunity Employer, committed to fostering an inclusive and diverse workplace. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status, or other applicable legally protected characteristics. For more information about personal rights under the U.S. Equal Opportunity Employment laws, visit:

　　EEOC Know Your Rights (https://www.eeoc.gov/sites/default/files/2022-10/22-088_EEOC_KnowYourRights_10_20.pdf)

　　EEOC GINA Supplement​

　　Pay Transparency Nondiscrimination (https://www.dol.gov/sites/dolgov/files/OFCCP/pdf/pay-transp_%20English_formattedESQA508c.pdf)

　　We are proud to be a company that embraces the value of bringing diverse, talented, and committed people together. The fastest way to breakthrough innovation is when diverse ideas come together in an inclusive environment. We encourage our colleagues to respectfully challenge one another’s thinking and approach problems collectively.

　　Learn more about your rights, including under California, Colorado and other US State Acts (https://www.msdprivacy.com/us/en/CCPA-notice/)

　　U.S. Hybrid Work Model

　　Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, generally Tuesday, Wednesday and either Monday or Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence. This Hybrid work model does not apply to, and daily in-person attendance is required for, field-based positions; facility-based, manufacturing-based, or research-based positions where the work to be performed is located at a Company site; positions covered by a collective-bargaining agreement (unless the agreement provides for hybrid work); or any other position for which the Company has determined the job requirements cannot be reasonably met working remotely. Please note, this Hybrid work model guidance also does not apply to roles that have been designated as “remote”.

　　Under New York State, Colorado State, Washington State, and California State law, the Company is required to provide a reasonable estimate of the salary range for this job. Final determinations with respect to salary will take into account a number of factors, which may include, but not be limited to the primary work location and the chosen candidate’s relevant skills, experience, and education.

　　Expected salary range:

　　$164,800.00 - $259,400.00

　　Available benefits include bonus eligibility, health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and sick days. For Washington State Jobs, a summary of benefits is listed here (https://www.benefitsatmerck.com/) .

　　Search Firm Representatives Please Read Carefully

　　Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.

　　Employee Status:

　　Regular

　　Relocation:

　　Domestic

　　VISA Sponsorship:

　　No

　　Travel Requirements:

　　10%

　　Flexible Work Arrangements:

　　On-Site

　　Shift:

　　Not Indicated

　　Valid Driving License:

　　No

　　Hazardous Material(s):

　　n/a

　　Requisition ID: R274792